Quarterly Sales and EPS Roundup:
Celgene Corporation (CELG) reported sales (ttm) of 11.68 Billion, whereas, 20 number of analysts estimated the mean sale of 3417.1 million. The analysts estimated sales for the higher end at 3540.4 million and lower end at 3321.99 million while the year ago reported sale was 3344.54 million.
20 number of analysts have estimated the sales of the company for the quarter, analysts estimated mean sale target of 3572.1 million while high and low sale targets are estimated at 3750.6 million and 3398.8 million respectively.
Celgene Corporation (CELG) reported earning per shares for the quarter ending Jul 27 BMO, whereas, 23 number of analysts estimated the mean EPS at 1.88. The analysts estimated EPS for the higher end at 2.01 and lower end at 1.82 while the year ago reported earnings per share was 1.79.
The company has mean EPS estimate of 1.96 reported by 23 number of analyst for the quarter ending Current Qtr.(Jun2017). The analysts estimated mean EPS at 1.96 while the high and low EPS estimate stand at 2.14 and 1.86 respectively. In contrast to the year ago quarter EPS was at 1.88. EPS long term mean growth rate estimated by 10 analysts is at 20.72%, whereas, the high and low Long term growth rate estimated at 27.18 and 13.09.
Valuation Ratios of Celgene Corporation (CELG) versus the Industry and Sector:
Let’s have a look at some of the important valuation ratios of the Celgene Corporation (CELG). These ratios are important while doing valuation of the company or the shares of the company.
Celgene Corporation (CELG) currently has P/E (Price to Earnings) ratio of 50.69 while the company’s industry has 158.56 P/E and the sector P/E is 17.23. Similarly, the company’s last 5 years high P/E ratio is 61.67 and low P/E is 23.75, whereas, the industry’s and sector’s high P/E for the past year is 231.78 and 43.61 respectively and low P/E ratio for the last 5 years is 78.95 for the industry and 23.34 for the Sector.
Beta is also an important valuation ratio for analyzing the stock of the company, CELG has Beta of 1.9 while its industry and Sector’s beta remains at 0.96 and 0.89 respectively.
Price to Sale ratio of CELG stands at 9 while Price to Book Ratio stands at 13.75. Its Price to Cash Flow ratio shows the value of 35.08, whereas, the industry and sector ratio of Price to Cash Flow ticked at 59.99 and 10.42 respectively.
5 Year Growth Rate Analysis:
Growth rates are very important while analyzing the long term growth and valuation of a certain company.
5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of Celgene Corporation (CELG) stands at 18.32 while the industry’s and the sector’s growth for next 5 years ticked at 25.9 and 10.49 respectively. The company’s 5 year Earnings per share growth and Capital Spending growth remains at 11.81 and 12.32.
Celgene Corporation (CELG) Trading Statistics:
The company surged 0.07% and closed its last trading session at $134.47. The market capitalization of the company is at $105 Billion. The stock touched 52-week High of $135.99 on 07/13/17 and 52-week Low of $96.93 on 10/25/16. The stock currently has Weekly Volatility of 1.70% and Monthly Volatility of 2.16%. The Beta for the company stands at 1.9 and its Average True Range (ATR) shows a value of 2.58.